(Q37544976)

20 August 2017

1 reference

title

Urinary prostate cancer 3 test: toward the age of reason? (English)

1 reference

Virginie Vlaeminck-Guillem

20 August 2017

1 reference

1

object named as

Virginie Vlaeminck-Guillem

0 references

author name string

Alain Ruffion

2

1 reference

20 August 2017

Jean André

3

1 reference

20 August 2017

Marian Devonec

4

1 reference

20 August 2017

Philippe Paparel

5

1 reference

20 August 2017

language of work or name

English

0 references

publication date

8 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

75

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

447-453

1 reference

Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Use of multiple biomarkers for a molecular diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Molecular characterization of human prostate carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Molecular PCA3 diagnostics on prostatic fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

uPM3, a new molecular urine test for the detection of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

PCA3: a molecular urine assay for predicting prostate biopsy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Prostate cancer detected by uPM3: radical prostatectomy findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.046

10.1016/J.UROLOGY.2009.03.046

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference